HLS Therapeutics Inc.
|
|||
| Mailing Address: | 10 Carlson Court Suite 701 Etobicoke, Ontario M9W6L2 |
Head Office Address: | 10 Carlson Court Suite 701 Etobicoke, Ontario M9W6L2 |
| Contact Name: | Ryan C. Lennox, Senior Vice-President, Legal, HR and Compliance | Principal Regulator: | Ontario |
| Business e-mail address: | r.lennox@hlstherapeutics.com | Short Form Prospectus Issuer: | Yes |
| Telephone Number: | 647 495-9000 | Reporting Jurisdictions: | British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland, North West Territories, Yukon, Nunavut |
| Fax Number: | Stock Exchange: | TSX | |
| Date of Formation: | Mar 12 2018 | Stock Symbol: | HLS |
| Jurisdiction Where Formed: | Ontario | Auditor: | Ernst & Young LLP |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
| CUSIP Number: | 40390B | Transfer Agent: | Computershare Investor Services Inc. |
| Financial Year-End: | Dec 31 | Size of Issuer (Assets): | $100,000,001 to $500,000,000 |
|
